Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02927990 · ClinicalTrials.gov registry record
Contrast Volume Reduction During PCI With the Use of a New Assisting Software Package
A clinical trial, sponsored by Philips Clinical & Medical Affairs Global.
- Terminated
- Registry status
- 80
- Enrollment target
NCT02927990 is a clinical trial that was terminated before completion, run by Philips Clinical & Medical Affairs Global. The registered enrollment target is 80 participants.
The verdict
NCT02927990 was terminated before completion, sponsored by Philips Clinical & Medical Affairs Global.
- TERMINATED
- Registry status
- 80 participants
- Enrollment target
Study Summary
The new software package is intended to assist the physician in imaging the coronaries during percutaneous coronary interventions. This study investigates the amount of contrast used during percutaneous coronary interventions with the aid of the new software package. The results of the study will be compared with control group data (before the new software package was installed or after it was removed) to define a possible contrast reduction.
Interventions
- OTHER Percutaneous Coronary Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2017-12-15 |
| Est. Completion | 2019-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02927990
The ClinicalTrials.gov registry entry for NCT02927990 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Philips Clinical & Medical Affairs Global, which has 45 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Percutaneous Coronary Intervention is the first listed.
NCT02927990 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02927990 about?
NCT02927990 is a clinical study titled "Contrast Volume Reduction During PCI With the Use of a New Assisting Software Package". The new software package is intended to assist the physician in imaging the coronaries during percutaneous coronary interventions. This study investigates the amount of contrast used during percutaneous coronary interventions with the aid of the new software package. The results of the study will ...
What is the current status of trial NCT02927990?
This trial is currently terminated. The enrollment target is 80 participants. The study started on 2017-12-15. Estimated completion is 2019-06-30.
What interventions are being tested in trial NCT02927990?
The interventions under investigation include: Percutaneous Coronary Intervention (OTHER).
Who is sponsoring clinical trial NCT02927990?
This trial is sponsored by Philips Clinical & Medical Affairs Global, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.